BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26106003)

  • 41. High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party.
    Akhtar S; Montoto S; Boumendil A; Finel H; Masszi T; Jindra P; Nemet D; Fuhrmann S; Beguin Y; Castagna L; Ferrara F; Capria S; Malladi R; Moraleda JM; Bloor A; Ghesquières H; Meissner J; Sureda A; Dreger P
    Am J Hematol; 2018 Jan; 93(1):40-46. PubMed ID: 28971503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nodular lymphocyte-predominant Hodgkin lymphoma.
    Savage KJ; Mottok A; Fanale M
    Semin Hematol; 2016 Jul; 53(3):190-202. PubMed ID: 27496311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
    Moore EM; Swerdlow SH; Gibson SE
    Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma.
    Song JY; Eberle FC; Xi L; Raffeld M; Rahma O; Wilson WH; Dunleavy K; Pittaluga S; Jaffe ES
    Am J Surg Pathol; 2011 May; 35(5):767-72. PubMed ID: 21490448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A case of composite classical and nodular lymphocyte predominant Hodgkin lymphoma with progression to diffuse large B-cell non-Hodgkin lymphoma: Diagnostic difficulty in fine-needle aspiration cytology.
    Das DK; Sheikh ZA; Al-Shama'a MH; John B; Alawi AM; Junaid TA
    Diagn Cytopathol; 2017 Mar; 45(3):262-266. PubMed ID: 27888658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymphocyte-rich classical Hodgkin lymphoma (LRCHL): clinico-pathological characteristics and outcome of a rare entity.
    de Jong D; Bosq J; MacLennan KA; Diebold J; Audouin J; Chasle J; Mandard AM; Marnay J; Henry-Amar M; ;
    Ann Oncol; 2006 Jan; 17(1):141-5. PubMed ID: 16284059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. VII. Management of nodular lymphocyte-predominant Hodgkin lymphoma.
    Eichenauer DA; Engert A
    Hematol Oncol; 2013 Jun; 31 Suppl 1():47-50. PubMed ID: 23775649
    [No Abstract]   [Full Text] [Related]  

  • 48. [Nodular lymphocyte predominant Hodgkin lymphoma (paragranuloma of Poppema) in children: Case report, review of the literature and treatment].
    Wilgenhof K; Théate I; Devalck C; Forsyth R; Dehou MF
    Ann Pathol; 2023 Jan; 43(1):39-44. PubMed ID: 36008237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging.
    Lyapichev KA; You MJ; Vega F; Solis LM; Medeiros LJ
    Virchows Arch; 2020 Sep; 477(3):437-444. PubMed ID: 32152665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple Cavitary Lung Lesions in an Adolescent: Case Report of a Rare Presentation of Nodular Lymphocyte Predominant Hodgkin Lymphoma.
    Soliman M; Neemuchwala F; Sankar A; Jasty R; Rabah R; Popova AP; Newman EA
    J Pediatr Hematol Oncol; 2018 Oct; 40(7):e454-e457. PubMed ID: 30102646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reed-Sternberg-Like Cells in Non-Hodgkin Lymphomas.
    Gomez-Gelvez JC; Smith LB
    Arch Pathol Lab Med; 2015 Oct; 139(10):1205-10. PubMed ID: 26414463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Review of Current Literature and Case Discussion.
    Sidda A; Naleid NK; Manu G; Graffeo V; Jamil MO
    J Investig Med High Impact Case Rep; 2022; 10():23247096221111767. PubMed ID: 35861500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discordant lymphoma consisting of mediastinal large B-cell lymphoma and nodular sclerosis Hodgkin lymphoma in the right supraclavicular lymph nodes: a case report.
    Zhang C; Yi Y; Chen C; Wang J; Liu Z
    Diagn Pathol; 2015 Dec; 10():215. PubMed ID: 26715530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications.
    Gloghini A; Bosco A; Ponzoni M; Spina M; Carbone A
    Expert Rev Hematol; 2015 Apr; 8(2):217-23. PubMed ID: 25487651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nodular lymphocyte predominant Hodgkin lymphoma with clusters of LP Cells, acute inflammation, and fibrosis: a syncytial variant.
    Drakos E; Rassidakis GZ; Leventaki V; Cotta CV; Vega F; Medeiros LJ
    Am J Surg Pathol; 2009 Nov; 33(11):1725-31. PubMed ID: 19730363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma.
    Cho BB; Kelting SM; Gru AA; LeGallo RD; Pramoonjago P; Goldin TA; Heitz CT; Aguilera NS
    Ann Diagn Pathol; 2017 Feb; 26():10-15. PubMed ID: 28038705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management.
    Hawkes EA; Wotherspoon A; Cunningham D
    Leuk Lymphoma; 2012 Mar; 53(3):354-61. PubMed ID: 21812538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Specific infiltrate of Hodgkin lymphoma at site of cellulitis mimicking secondary cutaneous involvement.
    Facheris P; Valenti M; Pavia G; Grizzi F; Narcisi A; Costanzo A; Borroni RG
    J Cutan Pathol; 2020 May; 47(5):462-465. PubMed ID: 31769877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
    Wu D; Thomas A; Fromm JR
    Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.